Ba Marita Engel - Nanotechnology

Author Information

Bastian Engel is affiliated with the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School in Hannover, Germany. Additionally, he is part of the European Reference Network on Hepatological Diseases (ERN RARE-LIVER) in Germany.

Research Contributions

Bastian Engel has made significant contributions to the field of hepatology and gastroenterology, with a particular focus on liver diseases, including liver fibrosis, autoimmune hepatitis, and liver transplantation. His research includes the therapeutic use of HNF4A mRNA for liver fibrosis, systematic reviews of response criteria in autoimmune hepatitis, and the study of genetic aspects of autoimmune hepatitis. He has also contributed to advancements in personalized immunosuppression programs post-liver transplantation and the molecular signatures associated with autoimmune hepatitis.

Aliases

B Engel, B. Engel, Ba Marita Engel, Bastian Engel

Publication and Citation Metrics

Metric	Value
Citation Count	307
H-index	11
Paper Count	38

Publications:

Corrigendum to 'Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model' [J Hepatol (2021) 1420-1433].

DOI: 10.1016/j.jhep.2022.03.023

Year: 2022

Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.

DOI: 10.1016/j.jhep.2021.12.041

Year: 2022

mRNA therapeutics for liver diseases: HNF4A mRNA delivery via lipid nanoparticles attenuates liver fibrosis in preclinical models.

DOI: 10.1055/s-0041-1740682

Year: 2022

Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model.

DOI: 10.1016/j.jhep.2021.08.011

Year: 2021

Genetic aspects of adult and pediatric autoimmune hepatitis: a concise review.

DOI: 10.1016/j.ejmg.2021.104214

Year: 2021

Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation

DOI: 10.1111/ajt.16817

Year: 2021

Liver-first strategy for a combined lung and liver transplant in patients with cystic fibrosis.

DOI: 10.1093/ejcts/ezab164

Year: 2021

Distinct Immune Imprints of Post–Liver Transplantation Hepatitis C Persist Despite Viral Clearance

DOI: 10.1002/lt.26031

Year: 2021

Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis

DOI: 10.1002/hep.32134

Year: 2021

Distinct intrahepatic molecular signature between relapse and sustained remission of autoimmune hepatitis before initiation of immunosuppression withdrawal

DOI: 10.1016/s0168-8278(20)30900-4

Year: 2020

What are the Challenges in Data Availability?

What Role Do Regulations Play in Preventing Data Leakage in Nanotechnology?

Are There Environmental Concerns Associated with Marine Nanotechnology?

How Are Interactive 3D Plots Created?

What are Nonlinear Optical Phenomena?

What is the Intellectual Property Landscape?

What is High Resolution Spectroscopy?

Why is Nanotechnology Education Important?

What Are Nanosensors?

Why Pursue a Certification in Nanotechnology?

Partnered Content Networks

Relevant Topics